Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate works similarly to other treatments for hirsutism, but more research is needed.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Baricitinib may not always prevent relapse in alopecia areata.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

PRP is a promising alternative for alopecia areata due to its safety and patient satisfaction.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Flutamide and CPA are more effective than finasteride for treating acne in hyperandrogenic women.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Mirtazapine may cause hair loss and change hair color, but stopping the drug can reverse these effects.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

Blocking 5α-reductase can reduce sleep deprivation-related behavioral issues in rats.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Ritlecitinib helps hair regrowth and reduces emotional and functional burdens in alopecia areata.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Isolation stress in rats reduces brain enzyme levels, affecting dopamine function.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.